Compounds > 4-aminopyridine
Page last updated: 2024-10-21

4-aminopyridine and Cardiomyopathies

4-aminopyridine has been researched along with Cardiomyopathies in 2 studies

Cardiomyopathies: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Casis, O1
Gallego, M1
Iriarte, M1
Sánchez-Chapula, JA1
Kocic, I1
Hirano, Y1
Hiraoka, M1

Other Studies

2 other studies available for 4-aminopyridine and Cardiomyopathies

ArticleYear
Effects of diabetic cardiomyopathy on regional electrophysiologic characteristics of rat ventricle.
    Diabetologia, 2000, Volume: 43, Issue:1

    Topics: 4-Aminopyridine; Action Potentials; Animals; Cardiomyopathies; Cells, Cultured; Diabetes Mellitus, E

2000
Rate-dependent changes in action potential duration and membrane currents in hamster ventricular myocytes.
    Pflugers Archiv : European journal of physiology, 2002, Volume: 443, Issue:3

    Topics: 4-Aminopyridine; Action Potentials; Animals; Calcium; Cardiomyopathies; Cricetinae; Heart Ventricles

2002